Akari Therapeutics Plc (AKTX) Financials

AKTX Assets vs Liabilities

DateAssetsLiabilities
2023-06-30 8.0 million 5.2 million
2023-03-31 8012 5231
2022-12-31 13831 12040
2022-09-30 13831 12040

AKTX Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-06-30 -4786 270
2023-03-31 -4786 270
2022-12-31 -3940 256
2022-09-30 -3940 256

AKTX Net Income

No data available :(

AKTX Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-06-30 7.2 million - -
2023-03-31 7180 - -
2022-12-31 13249 - -
2022-09-30 13249 - -

AKTX Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-06-30 4393
2023-03-31 4393
2022-12-31 3419
2022-09-30 3419

AKTX Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-06-30 - 1627 2977 -
2023-03-31 - 1627 2977 -
2022-12-31 - 3444 3728 -
2022-09-30 - 3444 3728 -

AKTX Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-06-30 - -
2023-03-31 - -
2022-12-31 - -
2022-09-30 - -

AKTX

Price: $1.18

52 week price:
1.10
5.50

Earnings Per Share: -2.04 USD

P/E Ratio: -1

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 16739

Ebitda: -8.5 million

Market Capitalization: 9.6 million

Links: